News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
WEST AI Algorithm May Help Speed Diagnosis of Rare Diseases
April 14, 2026 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
- Our Impact on Rare Diseases
Rare diseases can take years to diagnose. WEST — a new AI algorithm — aims to cut that diagnostic odyssey by learning from complete and incomplete real-world EHR data.
Read Article
Transparency and Early Planning Are Key in Increasing Efficiency of Gene Therapy Development for Rare Diseases
February 26, 2026 - NCATS News
- Platform Vector Gene Therapy (PaVe-GT)
PaVe-GT scientists underscore strategy, framework and early interaction with the FDA to align preclinical and clinical efforts in AAV gene therapy translation.
Read ArticleNIH, FDA and 15 Private Organizations Join Forces to Increase Effective Gene Therapies for Rare Diseases
October 27, 2021 - NCATS News
- Bespoke Gene Therapy Consortium (BGTC)
- Platform Vector Gene Therapy (PaVe-GT)
NIH, FDA and 15 private organizations partnered to create the Bespoke Gene Therapy Consortium to speed development of FDA-approved gene therapies for rare diseases. The effort is co-led by NCATS and managed by FNIH.
NIH Study Suggests People with Rare Diseases Face Significantly Higher Health Care Costs
October 22, 2021 - NCATS News
Results from a collaborative pilot study suggest health care costs for each person with a rare disease are three to five times greater than the costs for those who do not have a rare disease.
New Method Could Help Find Potential Treatments for Rare Diseases
January 5, 2019 - NCATS News
- Preclinical Chemical Biology Laboratory
Scientists in NCATS’ Assay Development and Screening Technology Program are developing new methods for screening small molecules that could help researchers test possible drugs and develop new treatments for many diseases.